Europe Archives - Page 53 of 93 - Journal for Clinical Studies

Current Edition

Europe

FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome

BERLIN, GERMANY, September 25, 2018 - Myelo Therapeutics GmbH announced today that the US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to...

27 September 2018 Europe | news | Regional News

Continue Reading →

Australasia

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical device pr...

21 September 2018 Australasia | Europe | news | Regional News

Continue Reading →

Europe

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the ...

20 September 2018 Europe | news | Regional News

Continue Reading →

Europe

Landmark MS trial launches in UK

The biggest ever trial for secondary progressive multiple sclerosis (SPMS) has kicked off in the UK at around 30 sites in England, Scotland, Wales, Northern I...

20 September 2018 Europe | news | Regional News

Continue Reading →

Europe

The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budeso...

20 September 2018 Europe | news | Regional News

Continue Reading →

Europe

Positive Phase 3 results presented for Dupixent® (dupilumab) show significant improvement on multiple measures of disease severity in adolescents with moderate-to-severe atopic dermatitis

Results on skin clearing, itch and certain quality of life measurements were presented today as a late-breaking oral presentation at the 27th EADV Congress Par...

20 September 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

Alzheimer’s disease: amyloid β protein once again in the spotlight as a therapeutic target

World Alzheimer's Day on 21 September 2018 (Vienna, 18 September 2018) For many years amyloid β protein was considered to be a promising therapeutic target in Alz...

20 September 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

Persons with Alzheimer’s disease are more often hospitalized after initiating antibiotic use

Persons with Alzheimer’s disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finla...

20 September 2018 Europe | news | Regional News

Continue Reading →

Asia Pacific

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®) Paris and Toulou...

Continue Reading →

Europe

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer

Bavarian Nordic-sponsored study has commenced dosing Study marks the second of three planned Phase 2 combination studies of CV301 with checkpoint inhibitors in s...

20 September 2018 Europe | news | Regional News

Continue Reading →